InvestorsHub Logo
Followers 33
Posts 3372
Boards Moderated 0
Alias Born 04/27/2011

Re: None

Wednesday, 08/26/2015 9:58:41 AM

Wednesday, August 26, 2015 9:58:41 AM

Post# of 24352
I'm sure everyone knows that the new website is up: Nano Mobile Healthcare, Inc.

http://nanomobilehealthcare.com/investors

But what I don't think I've seen is that there is a line, the 4th line or bullet point under Investment Highlights that says:
__________________________________________________________________
Website Quote: "FDA clinical trials are expected to start in 2015 and commercialization in 2016 for the Lung Cancer App."
__________________________________________________________________

I didn't see that before in live print, am I wrong?

Here's the whole thing (page that is)


You are here
Home » INVESTORS

[OTCB: VNTH] Stock Quote Press Releases Investor FAQs SEC Filings
Nano Mobile Healthcare, Inc. | Investor Fact Sheet

Nano Mobile Healthcare, Inc. (OTCQB: VNTH) – Founded in 2010 and headquartered in New York City and Mountain View, CA is a leading mobile health technology company developing point-of-care screening using Apps based upon chemical sensing residing within a small Bluetooth enabled device that works with any smartphone, tablet or laptop called the Nano Mobile Sensor.
INVESTMENT HIGHLIGHTS

With its foundations in advanced nanotechnology, the Company’s first product, the Nano Mobile Sensor, is the convergence of nano-electronics, bio-informatics, and wireless technology to create the next generation mobile health application.

NASA Invention of the Year was awarded in April 2013.
NASA grants five-year exclusive worldwide license to the company for IP associated with all patents issued and pending for commercialization in areas of healthcare and narcotics.
Strategic Partnership for Mobile Health Technology with Scripps Translational Science Institute is announced.
FDA clinical trials are expected to start in 2015 and commercialization in 2016 for the Lung Cancer App.[color=blue][/color]
Total Addressable Market for lung cancer (four main global regions) one year is $3.0 Billion for Healthcare Providers.
Marketing initially to Healthcare Providers through strategic large pharmaceutical partners.
Business model is subscription based with recurring revenue occurring after purchase of device and monthly subscription fee per application.
Business model delivers value to all parties (Healthcare Providers, Pharmacy, Patients and Insurance Companies).
Ongoing research collaborations with NASA and the Scripps Translational Science Institute.


OUR TECHNOLOGY – THE NANO MOBILE SENSOR

The Nano Mobile Sensor was birthed via NASA by taking care of the astronauts in space, ensuring the quality of their air was free of carbon monoxide and other noxious gases. Our founder and Chief Scientist, before his life here at Nano Mobile, was a rocket scientist himself and repurposed the device with other scientists on the sensor team, to read our breath signature.
Everyone’s breath is composed of Volatile Organic Compounds and combinations of them can form giving Doctors indications of various illnesses that are present in our bodies. Those same VOC compounds can be used to detect marijuana and other legal and illegal drugs present in our bodies.
The Nano Mobile Sensor is designed to screen for these various combinations so the doctor can identify them before symptoms appear, such as a tumor that appears when patients have a CT scan, which means patients will have many more treatment options available.
The fact that this technology will be Bluetooth enabled means that the Nano Mobile Sensor is small and compact and works with any smartphone, tablet or laptop making the data collected in real-time and immediately available for analysis to doctor and patient. In the case of law enforcement it means that an officer can detect in real time whether a driver has marijuana present in their body.
The Nano Mobile Sensor will automatically self-flush after each use so the Healthcare Provider can use the sensor with different patients as well as use the same sensor for different screening applications. In the case of law enforcement the officer can test the driver of all involved and get the results in real time.


THE UNMET NEED AND SOLUTIONS FOR CANCER DETECTION

There are more deaths from Lung Cancer than from Prostate, Breast and Colorectal combined.
Only 15 percent of lung cancer cases are screened at an early stage.
The five-year survival rate for lung cancer is 67% percent for cases detected at stage 1A when the disease is still localized.
For stage 4 lung cancer, the five-year survival rate is only 2.5 percent and this is why most people with stage 4 lung cancer die within one year of being diagnosed.
There is an opportunity for low cost non-invasive detection of this disease at its earliest stages when treatment options are many and varied and lives can be saved.
Our Vision involves a Nano Mobile Sensor for each Healthcare Provider with the desire to screen for early indications of lung cancer.
We believe Healthcare Provider and patients will find breath analysis attractive – non-invasive, painless, having no side effects and available at an extremely low cost.
Our goal is to, with a strategic partner(s), commercialize mobile breath sensor technologies, with initial screening for lung cancer, that enable Healthcare Provider to better manage the health care continuum from managing illness to managing wellness.
Early, non-invasive, inexpensive lung cancer screening is the first step in reducing deaths and lowering healthcare costs.
Once the lung cancer application is launched (expected in 2016), Nano Mobile will start work on the next applications in the pipeline related to breast cancer, colorectal cancer, prostate cancer and other cancers and infectious diseases.


THE UNMET NEED AND SOLUTIONS FOR MOBILE MARIJUANA DETECTION

Marijuana is the number one illicit drug in America and the concentrations of THC in marijuana is three times more powerful than in the 1980’s. Fatalities from marijuana use by drivers is rising.
At a time when we are seeing an increase in state by state legislative approvals for medical marijuana, it is inevitable that increased marijuana use will also correlate to impaired driving. Law enforcement needs mobile technology to save lives.
Law enforcement will need the Nano Mobile Sensor for detecting drivers under the influence of marijuana so they may in turn help protect our communities and save lives.
Nano Mobile, through its majority shareholder Nanobeak, is working with NASA to develop a capability which would specifically result in a test for marijuana.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VNTH News